Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Zealand Pharma - Filing #1382857

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
972,041,000 EUR
758,887,000 EUR
673,527,000 EUR
Revenue
103,986,000 EUR
108,546,000 EUR
192,001,000 EUR
Profit (loss) from discontinued operations
236,525,000 EUR
263,211,000 EUR
178,016,000 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
942,209,000 EUR
1,211,971,000 EUR
688,716,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
281,259,000 EUR
18,121,000 EUR
196,807,000 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
587,398,000 EUR
1,332,751,000 EUR
760,941,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.